Personalis, Inc. (PSNL)

16.78 -0.29 (-1.70%) USD  |  NASDAQ  |  Aug 31, 16:00
17.18 +0.40 (+2.38%) After-Hours: 20:00
More

Personalis Cash from Operations (Annual) : -74.95M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for PSNL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2017. Start Trial.
Date Value
December 31, 2025 -74.95M
December 31, 2024 -45.15M
December 31, 2023 -56.26M
December 31, 2022 -70.23M
December 31, 2021 -70.83M
Date Value
December 31, 2020 -42.65M
December 31, 2019 -18.07M
December 31, 2018 5.572M
December 31, 2017 0.29M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Tempus AI, Inc. -218.09M
10X Genomics, Inc. 136.05M
Alamar Biosciences, Inc. (California) -53.61M
Adaptive Biotechnologies Corp. -45.99M
Champions Oncology, Inc. -4.472M